Composition
- Active ingredients
- SAXAGLIPTIN HYDROCHLORIDE EQ 5MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- SAXAGLIPTIN HYDROCHLORIDE EQ 2.5MG BASE · TabletANDA205941-001 · Discontinued
- SAXAGLIPTIN HYDROCHLORIDE EQ 5MG BASE · TabletANDA205941-002 · Discontinued
- SAXAGLIPTIN HYDROCHLORIDE EQ 5MG BASE · TabletANDA205994-002 · Prescription
- SAXAGLIPTIN HYDROCHLORIDE EQ 2.5MG BASE · TabletANDA205994-001 · Prescription
- SAXAGLIPTIN HYDROCHLORIDE EQ 5MG BASE · TabletANDA205972-002 · Prescription
- SAXAGLIPTIN HYDROCHLORIDE EQ 2.5MG BASE · TabletANDA205972-001 · Prescription
- SAXAGLIPTIN HYDROCHLORIDE EQ 5MG BASE · TabletANDA205980-002 · Prescription
- SAXAGLIPTIN HYDROCHLORIDE EQ 2.5MG BASE · TabletANDA205980-001 · Prescription
- SAXAGLIPTIN HYDROCHLORIDE EQ 2.5MG BASE · TabletANDA206078-001 · Discontinued
- SAXAGLIPTIN HYDROCHLORIDE EQ 5MG BASE · TabletThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA206078.
At a glance
- Brand name
- Saxagliptin
- Active substance
- saxagliptin hydrochloride
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Sun Pharm
- Status
- Discontinued
- FDA approval
- 31 Jul 2023
- Application
- ANDA206078-002